evertex fabrinology limited

TWSE:1470 Stock Report

Market Cap: NT$1.8b

evertex fabrinology Past Earnings Performance

Past criteria checks 3/6

evertex fabrinology's earnings have been declining at an average annual rate of -2.8%, while the Luxury industry saw earnings growing at 9.3% annually. Revenues have been declining at an average rate of 2.1% per year. evertex fabrinology's return on equity is 6.6%, and it has net margins of 9.4%.

Key information

-2.8%

Earnings growth rate

-2.7%

EPS growth rate

Luxury Industry Growth8.2%
Revenue growth rate-2.1%
Return on equity6.6%
Net Margin9.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Recent updates

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Revenue & Expenses Breakdown

How evertex fabrinology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TWSE:1470 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24702661060
30 Jun 24651601010
31 Mar 2461345940
31 Dec 2365549960
30 Sep 2363749920
30 Jun 2371756970
31 Mar 23777411000
31 Dec 22845331060
30 Sep 22951501080
30 Jun 22968501130
31 Mar 22993861200
31 Dec 21895651130
30 Sep 21858671150
30 Jun 21773631070
31 Mar 2162625920
31 Dec 2063135960
30 Sep 20647321050
30 Jun 20695401130
31 Mar 20815721260
31 Dec 19818761280
30 Sep 19814791240
30 Jun 19802771220
31 Mar 19792621210
31 Dec 18754491160
30 Sep 18735471140
30 Jun 18704361110
31 Mar 18693401110
31 Dec 17701421130
30 Sep 17711421150
30 Jun 17703391140
31 Mar 17682401100
31 Dec 16686471070
30 Sep 16687501030
30 Jun 16713641000
31 Mar 1674562980
31 Dec 1576261980
30 Sep 1577063990
30 Jun 1574754970
31 Mar 1574362950
31 Dec 1474466880
30 Sep 1473857830
30 Jun 1474858800
31 Mar 1470742750
31 Dec 1366929730

Quality Earnings: 1470 has a large one-off gain of NT$14.8M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 1470's current net profit margins (9.4%) are higher than last year (7.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1470's earnings have declined by 2.8% per year over the past 5 years.

Accelerating Growth: 1470's earnings growth over the past year (35.2%) exceeds its 5-year average (-2.8% per year).

Earnings vs Industry: 1470 earnings growth over the past year (35.2%) exceeded the Luxury industry 13.9%.


Return on Equity

High ROE: 1470's Return on Equity (6.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies